NCT00815724

Brief Summary

The National Heart, Lung, and Blood Institute (NHLBI) has established guidelines for treating people with asthma. This study will evaluate the effectiveness of a distance learning program that aims to educate doctors on these guidelines, specifically the use of inhaled corticosteroids to treat asthma in pediatric patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable asthma

Timeline
Completed

Started Feb 2007

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2007

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2008

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

December 29, 2008

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 30, 2008

Completed
Last Updated

March 11, 2013

Status Verified

March 1, 2013

Enrollment Period

1.1 years

First QC Date

December 29, 2008

Last Update Submit

March 7, 2013

Conditions

Asthma

Keywords

Daily Inhaled CorticosteroidsDistributed LearningE-learning

Outcome Measures

Primary Outcomes (2)

  • Change in physician asthma knowledge, attitudes, and treatment behavior

    Measured at Months 1 and 6

  • Learner satisfaction

    Measured at Months 1 and 6

Study Arms (2)

1

EXPERIMENTAL

Participants will take part in a distance learning group.

Behavioral: Distributed Asthma Learning Initiative (DALI) distance learning program

2

NO INTERVENTION

Participants in the control group will not receive any study materials or take part in any study activities.

Interventions

Distributed Asthma Learning Initiative (DALI) distance learning programBEHAVIORAL

Participants will take part in two Webinar teleconferences, have access to an interactive Web site, and receive a CD-ROM of study materials and a toolkit.

1

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Board-eligible pediatricians involved in direct primary care for children
  • Has access to a Windows or Macintosh computer with either a CD-ROM drive or Internet access
  • Has access to a telephone for teleconference calls
  • Willing to take part in the DALI educational seminar if assigned to the intervention group

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of California, San Francisco

San Francisco, California, 94118, United States

Location

MeSH Terms

Conditions

Asthma

Condition Hierarchy (Ancestors)

Bronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System Diseases

Study Officials

  • Michael D. Cabana, MD, MPH

    University of California, San Francisco

    PRINCIPAL INVESTIGATOR

  • Tao Le, MD

    University of Louisville

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 29, 2008

First Posted

December 30, 2008

Study Start

February 1, 2007

Primary Completion

March 1, 2008

Study Completion

March 1, 2008

Last Updated

March 11, 2013

Record last verified: 2013-03

Locations

US(1)